-+ 0.00%
-+ 0.00%
-+ 0.00%

Porsche (XTRA:P911) Could Be 7% Undervalued As It Pushes Further Upmarket

Simply Wall St·10/08/2026 16:23:50
Listen to the news

Porsche (XTRA:P911) has laid out an aggressive shift toward producing fewer, higher priced sports cars, targeting high end D and E segments, introducing new halo models above the 911, and tightening portfolio complexity.

For context, Dr. Ing. h.c. F. Porsche’s 1-day share price return of 0.33% to €42.67 comes after the stock fell 6.22% over the past week and 10.36% year to date. The 1-year total shareholder return of 2.41% contrasts with a 47.43% decline over three years, suggesting short term momentum has been soft as investors digest the shift toward higher priced, lower volume models and headcount reductions.

Compare Porsche’s move upmarket with other high end automakers by scanning our curated list of 618 high quality undiscovered gems that may be pursuing similar pricing power and brand-driven strategies.

Recent weakness and a push further upmarket put Dr. Ing. h.c. F. Porsche at an awkward crossroads. Does buying into the reset now make more sense than waiting for a cheaper entry once the new game plan is clearer?

Most Popular Narrative: 7% Undervalued

Dr. Ing. h.c. F. Porsche’s most followed narrative pegs fair value at €45.94, which sits modestly above the latest €42.67 close and frames today’s reset as a question of patience rather than deep value.

The company's strategic emphasis on product individualization, high-margin exclusivity programs (such as Sonderwunsch and paint-to-sample), and bespoke digital offerings, especially in key affluent markets like China, are likely to support higher average selling prices and revenue diversification, providing a buffer to volumes and stabilizing net margins.

See why 52 investors see Dr. Ing. h.c. F. Porsche as 7% undervalued.

Result: Fair Value of €45.94 (UNDERVALUED)

Still, the narrative around Dr. Ing. h.c. F. Porsche can shift quickly if China remains structurally weak or if luxury EV adoption drags out longer than analysts expect.

Find out about the key risks to this Dr. Ing. h.c. F. Porsche narrative.

Another View: Dr. Ing. h.c. F. Porsche Looks Expensive On Earnings

On a cash flow basis, Dr. Ing. h.c. F. Porsche screens as undervalued, trading about 15% below an estimated future cash flow value of €50.34. The picture changes when you look at the P/E. The stock trades on roughly 46.1x, which is far above the global auto group at 13.8x and also well above an estimated fair ratio of 19.7x. That gap points to meaningful valuation risk if sentiment around growth expectations cools.

See what the numbers say about this price — find out in our valuation breakdown.

XTRA:P911 P/E Ratio as at Oct 2026
XTRA:P911 P/E Ratio as at Oct 2026

Next Steps

Mixed signals around Dr. Ing. h.c. F. Porsche can easily pull you in both directions, so move quickly and dig into the data to test your own thesis, then round out that view with 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond Dr. Ing. h.c. F. Porsche?

If you stop with Dr. Ing. h.c. F. Porsche, you risk missing other opportunities, so put the Simply Wall Street Screener to work for you now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.